Volume 54, Issue 1, Pages (August 2009)

Slides:

Advertisements

Similar presentations

Two-Year Clinical Outcomes Yan Li MD., PhD. On behalf of FIREMAN Investigators Associated Professor of Department of Cardiology of Xijing Hospital Fourth.

Advertisements

Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons Presented at The American Heart Association Scientific Session 2006 Presented by Dr.

Slow-rate release polymer-based paclitaxel- eluting stent compared with bare stent in patients with single complex coronary lesions TAXUS V Presented at.

A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.

TLR Funnel plot (according to outcomes) for studies included in the meta-analysis Death A TVR B MACE DC SE(log OR)

Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.

Efficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS]) Young-Guk.

Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical restenosis after coronary stenting: perspectives.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Randomized Trial of Paclitaxel- Versus Sirolimus-Eluting.

Volume 60, Issue 3, Pages (September 2012)

Volume 68, Issue 4, Pages (October 2016)

Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three- Vessel Disease With the Routine Incorporation of Fractional Flow Reserve.

American Journal of Cardiology

Usefulness of Preprocedure High-Sensitivity C-Reactive Protein to Predict Death, Recurrent Myocardial Infarction, and Stent Thrombosis According to Stent.

American Heart Journal

Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries Young Joon Hong, MD, Myung Ho Jeong, MD, PhD, Weon Kim, MD,

Volume 64, Issue 2, Pages (August 2014)

Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

What Is the Best Practical Survey Method for the Comparative Assessment of Palliative Care Services: Results From A National Quality Assessment Project.

Volume 55, Issue 3, Pages (May 2010)

Effect of Left Ventricular Ejection Fraction on 2-year Clinical Cutcomes in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous.

LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary.

TAXUS IV Trial Slow-rate release polymer-based paclitaxel-eluting stent compared with bare stent in patients with single de novo coronary lesions Presented.

Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus- and Sirolimus-Eluting Stents (from the.

Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Circ Cardiovasc Interv

Circ Cardiovasc Interv

Circ Arrhythm Electrophysiol

Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Chronic Total Coronary Occlusion With Well‐Developed Collaterals by Se Yeon Choi,

What Is the Best Practical Survey Method for the Comparative Assessment of Palliative Care Services: Results From A National Quality Assessment Project.

Stenting of Coronary Arteries in Non Stress/Benestent Disease

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Repeated Target Vessel Revascularization After Coronary Artery Bypass for In-Stent Restenosis Jung-Hwan Kim, MD, Seung Hyun Lee, MD, PhD, Hyun-Chel Joo,

TAXUS II and IV: two-year follow-up

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Revascularization of the left anterior descending artery area using a single left internal thoracic artery: Auto-Y composite grafting or sequential bypassing

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Coronary Computed Tomography Angiography for Selecting Coronary Artery Bypass Graft Surgery Candidates Soo-Yeon Kim, MD, Hye-Jeong Lee, MD, PhD, Young.

American College of Cardiology Presented by Dr. Stephan Windecker

Long-term outcomes of percutaneous mitral balloon valvuloplasty versus open cardiac surgery Jae-Kwan Song, MD, Mi-Jeong Kim, MD, Sung-Cheol Yun, PhD,

Management of concomitant mild to moderate functional mitral regurgitation during aortic valve surgery for severe aortic insufficiency Ju Yong Lim, MD,

REALITY: 8 month results

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Presented at ACC 2003 Late Breaking Clinical Trials

The American College of Cardiology Presented by Dr. Raimund Erbel

SIRIUS: A U.S. Multicenter, Randomized, Double-Blind Study of the SIRolImUS-Eluting Stent in De Novo Native Coronary Lesions Presented at TCT 2002.

Late Referral to Palliative Care Services in Korea

Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease.

Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection Tae Jun Song, MD, PhD, Jae Hoon Lee, MD,

Febuxostat in Hyperuricemic Patients With Advanced CKD

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE.

Aortic Valve Replacement With Carpentier-Edwards: Hemodynamic Outcomes for the 19-mm Valve Ji Hoon You, MD, PhD, Dong Seop Jeong, MD, PhD, Kiick Sung,

Outcomes of the single-stent versus kissing-stents technique in asymmetric complex aortoiliac bifurcation lesions Yongsung Suh, MD, Young-Guk Ko, MD,

A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: One-year angiographic results.

Infrainguinal angioplasty with drug-eluting stents and balloons

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Presented at TCT 2006.

Complete Revascularization of the Three-Vessel Territories Using a Left Internal Thoracic Artery Composite Graft Ho Young Hwang, MD, PhD, Hong Chul Oh,

Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J

Impact of final kissing balloon inflation after simple stent implantation for the treatment of non-left main true coronary bifurcation lesions in patients.

Association Between Asthma and Depression: A National Cohort Study

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial

The American College of Cardiology Presented by Dr. A. Abazid

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

TYPHOON Trial Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON) Trial Presented at.

Presentation transcript:

Volume 54, Issue 1, Pages 108-114 (August 2009) Bare-metal stents versus drug-eluting stents in large (≥3.5mm) single coronary artery: Angiographic and clinical outcomes at 6 months Jin Oh Na, (MD), Jin Won Kim, (MD, PhD), Cheol Ung Choi, (MD), Un Jung Choi, (MD), Seung Yong Shin, (MD), Hong Euy Lim, (MD, PhD), Eung Ju Kim, (MD, PhD), Seung-Woon Rha, (MD, PhD), Chang Gyu Park, (MD, PhD), Hong Seog Seo, (MD, PhD), Dong Joo Oh, (MD, PhD) Journal of Cardiology Volume 54, Issue 1, Pages 108-114 (August 2009) DOI: 10.1016/j.jjcc.2009.05.004 Copyright © 2009 Terms and Conditions

Figure 1 Six-month event-free incidences of target-lesion/vessel revascularization (A) and composite MACE (B). The cumulative 6-month incidence free from target-lesion and target-vessel revascularization, and MACE curves were comparable between the groups. TLR, target-lesion revascularization; TVR, target-vessel revascularization; MACE, major adverse cardiac events. Journal of Cardiology 2009 54, 108-114DOI: (10.1016/j.jjcc.2009.05.004) Copyright © 2009 Terms and Conditions

Figure 2 Six-month angiographic outcomes. Although late loss of bare-metal stents (BMS) was higher than that of drug-eluting stents (DES) (A), binary restenosis did not substantially differ between the groups (B). Journal of Cardiology 2009 54, 108-114DOI: (10.1016/j.jjcc.2009.05.004) Copyright © 2009 Terms and Conditions